# OnCo record orteronel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/orteronel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "orteronel" ;
  schema:name "Orteronel"@en ;
  schema:alternateName "TAK-700"@en ;
  schema:description "A more selective version of abiraterone that was meant to avoid the need for steroids. It delayed the cancer on scans but did not help men live longer, and was abandoned."@en ;
  schema:url <https://onco.cc/drugs/orteronel/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(15)70027-6> ;
  onco:status "withdrawn" ;
  onco:modality "small molecule" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:targets <https://onco.cc/targets/cyp17a1/> ;
  onco:companies <https://onco.cc/companies/takeda/> ;
  onco:terms <https://onco.cc/terms/arpi/>, <https://onco.cc/terms/castration-resistance/> ;
  onco:trials <https://onco.cc/trials/elm-pc-4-orteronel/> .
